MR imaging and single-photon emission CT findings after gene therapy for human glioblastoma

American Journal of Neuroradiology

Volumn 22, Issue 8, 2001, Pages 1517-1527

  Floeth, F W ^a   Aulich, A ^a   Langen, K J ^a   Burger, K J ^a   Bock, W J ^a   Weber, F ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GANCICLOVIR; GLI 328; IODOMETHYLTYROSINE; THYMIDINE KINASE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADULT; AGED; AMINO ACID TRANSPORT; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; GENE TARGETING; GENE THERAPY; GLIOBLASTOMA; HERPES SIMPLEX VIRUS 1; HUMAN; IMAGE INTENSIFIER; INJECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; RETROVIRUS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE THERAPY; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; NEUROSURGICAL PROCEDURES; POSTOPERATIVE PERIOD; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034834151     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Primary brain tumor incidence rates in four United States regions, 1985-1989: A pilot study
2. Resection, biopsy and survival in malignant glial neoplasms
3. Radiotherapy for high-grade gliomas
4. Survival in malignant glioma: Analysis of prognostic factors with special regard to cytoreductive surgery
5. Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumor and its influence on regrowth and prognosis
6. Survival in patients with recurrent glioma as a measure of treatment efficacy: Prognostic factors following nitrosourea chemotherapy
7. Molecular evaluation of biopsy and autopsy specimens from patients receiving in vivo retroviral gene therapy
8. A Phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir
9. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production
10. 11C]-L-methionine uptake in cerebral gliomas: A comparative study using SPECT and PET
11. Early postoperative magnetic resonance imaging following nonneoplastic cortical resection
12. MR of recurrent high-grade astrocytomas after intralesional immunotherapy
13. Serial MR in gene therapy for recurrent glioblastoma: Initial experience and work in progress
14. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
15. Tumor killing using the HSV-tk suicide gene
16. Imaging of adult central nervous system primary malignant gliomas. Staging and follow up
17. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma
18. Neurologic PET and SPECT
19. 18F]2-fluoro-2-deoxy-glucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia
20. Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study
21. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors
22. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose
23. Human cerebral neoplasms studied using MR spectroscopy: A review
24. Magnetic resonance spectroscopy guided brain tumor resection: Differentiation between recurrent glioma and radiation change in two diagnostically difficult cases
25. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: A serial proton magnetic resonance spectroscopy imaging study
26. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy
27. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy
28. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy
29. Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study
30. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy
31. Absolute concentrations of metabolites in the adult human brain in vivo: Quantification of localized proton MR spectra
32. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance
33. 124IMT and first clinical results
34. Uptake of iodine-123-alpha-methyltyrosine by gliomas and non-neoplastic brain lesions
35. First experience with 1-123-alpha-methyl-tyrosine SPECT in the 3-D radiation treatment planning of brain gliomas